Hoya Corp. (OTCMKTS:HOCPY - Get Free Report) gapped down prior to trading on Friday . The stock had previously closed at $144.75, but opened at $139.60. Hoya shares last traded at $139.53, with a volume of 2,548 shares traded.
Wall Street Analysts Forecast Growth
Several research analysts recently weighed in on HOCPY shares. Erste Group Bank raised Hoya from a "hold" rating to a "strong-buy" rating in a research note on Friday, May 23rd. Nomura Securities raised shares of Hoya to a "strong-buy" rating in a research report on Monday, August 18th. Finally, The Goldman Sachs Group raised shares of Hoya from a "hold" rating to a "strong-buy" rating in a report on Wednesday, July 23rd. Three research analysts have rated the stock with a Strong Buy rating, According to MarketBeat.com, the stock has a consensus rating of "Strong Buy".
Check Out Our Latest Stock Report on Hoya
Hoya Stock Performance
The stock's 50-day moving average is $131.31 and its 200-day moving average is $121.61. The company has a current ratio of 5.19, a quick ratio of 4.46 and a debt-to-equity ratio of 0.03. The firm has a market capitalization of $47.87 billion, a price-to-earnings ratio of 34.88, a PEG ratio of 3.10 and a beta of 0.94.
Hoya (OTCMKTS:HOCPY - Get Free Report) last announced its quarterly earnings data on Friday, August 1st. The technology company reported $1.05 earnings per share (EPS) for the quarter, beating analysts' consensus estimates of $1.04 by $0.01. Hoya had a return on equity of 21.01% and a net margin of 23.57%.The company had revenue of $1.53 billion for the quarter, compared to the consensus estimate of $1.47 billion. On average, analysts predict that Hoya Corp. will post 3.66 EPS for the current fiscal year.
Hoya Company Profile
(
Get Free Report)
HOYA Corporation, a med-tech company, provides high-tech and medical products worldwide. It operates through three segments: Life Care, Telecommunication, and Other. The company offers life care products, including eyeglass and contact lenses; medical endoscopes; intraocular lenses; laparoscopic surgical instruments; automatic endoscope cleaning equipment; and other medical related products, such as prosthetic ceramic fillers and metallic implants for orthopedics.
Featured Stories
This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.
Before you consider Hoya, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Hoya wasn't on the list.
While Hoya currently has a Strong Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Discover the 10 Best High-Yield Dividend Stocks for 2025 and secure reliable income in uncertain markets. Download the report now to identify top dividend payers and avoid common yield traps.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.